Literature DB >> 1936784

A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis.

B I Hirschowitz1.   

Abstract

Because esophagitis is a presumed "acid-peptic" disease, fasting gastric contents (volume and acid and pepsin concentrations) and basal and pentagastrin-stimulated acid and pepsin outputs were studied in 155 patients with endoscopically defined (and graded 1-4) esophagitis and 508 control patients without esophagitis. Basal pepsin and maximal acid and pepsin outputs were lower in the patients with esophagitis than in those without esophagitis. In further analysis, the patients were subdivided into three categories, duodenal ulcer, nonulcer with no disease other than esophagitis, and postgastric surgery, because these categories affect gastric secretion independently of esophageal disease and in the rank order given. Each category was subdivided by sex, because men secreted more than women. Within each category there was no systematic difference in fasting, basal, or maximal gastric acid or pepsin secretion between patients with and patients without esophagitis. Severity of esophagitis was not related to any secretion parameters. Hiatal hernia was present in 50% of patients with esophagitis vs. 15% of controls without the condition (P less than 0.01); however, this did not independently influence the gastric secretion findings. Lower esophageal sphincter pressure was also measured in 62 of the patients, 31 with and 31 without esophagitis. Below 10 mm Hg (incompetent sphincter), 9 of 10 patients had esophagitis but accounted for only less than 30% of the patients with esophagitis, whereas none of 11 patients with basal acid output of less than 0.1 mEq/h and lower esophageal sphincter pressure of greater than 10 mm Hg had esophagitis. Because neither the composition of gastric juice nor basal or stimulated gastric acid or pepsin output could be correlated to the presence or severity of esophagitis, factors other than amount or composition of gastric juice per se must be responsible for susceptibility to esophagitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936784     DOI: 10.1016/0016-5085(91)90062-p

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  56 in total

1.  Anti-relaxation therapy in GORD.

Authors:  J Tack; D Sifrim
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

Review 2.  What is potent acid inhibition, and how can it be achieved?

Authors:  Xavier Calvet; Fernando Gomollón
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  GERD: increased gastric acid secretion as a possible cause of GERD.

Authors:  Jerry D Gardner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03       Impact factor: 46.802

4.  Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.

Authors:  G H Koek; D Sifrim; T Lerut; J Janssens; J Tack
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

5.  Gastric acid normosecretion is not essential in the pathogenesis of mild erosive gastroesophageal reflux disease in relation to Helicobacter pylori status.

Authors:  Tomohiko Shimatani; Masaki Inoue; Nobue Harada; Yoko Horikawa; Masuo Nakamura; Susumu Tazuma
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

6.  Ulcerogenic and intestinal motility/transit stimulating actions of nevirapine in albino Wistar rats.

Authors:  Elizabeth Bassey Umoren; Agona Odeh Obembe; Eme Effiom Osim
Journal:  J Physiol Biochem       Date:  2013-03-28       Impact factor: 4.158

7.  Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients.

Authors:  E Kuster; E Ros; V Toledo-Pimentel; A Pujol; J M Bordas; L Grande; C Pera
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

Review 8.  NERD: an umbrella term including heterogeneous subpopulations.

Authors:  Edoardo Savarino; Patrizia Zentilin; Vincenzo Savarino
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

9.  Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats.

Authors:  Kenji Nagahama; Masanori Yamato; Hikaru Nishio; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

10.  Significant increase of esophageal mucin secretion in patients with reflux esophagitis after healing with rabeprazole: its esophagoprotective potential.

Authors:  Irene Sarosiek; Mojtaba Olyaee; Marek Majewski; Elena Sidorenko; Katherine Roeser; Sandra Sostarich; Grzegorz Wallner; Jerzy Sarosiek
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.